157 related articles for article (PubMed ID: 15593029)
1. An underdiagnosed type of diabetes: the MODY syndromes. Pathophysiology, clinical presentation and renal disease progression.
Tsakiris D; Ioannou K
J Nephrol; 2004; 17(5):637-41. PubMed ID: 15593029
[TBL] [Abstract][Full Text] [Related]
2. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization.
Owen K; Hattersley AT
Best Pract Res Clin Endocrinol Metab; 2001 Sep; 15(3):309-23. PubMed ID: 11554773
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factors and type 2 diabetes.
Froguel P
Schweiz Med Wochenschr; 1998 Dec; 128(49):1936-9. PubMed ID: 9887471
[TBL] [Abstract][Full Text] [Related]
4. [Diabetes mellitus].
Iwasaki N
Rinsho Byori; 2001 Feb; 49(2):161-4. PubMed ID: 11307309
[TBL] [Abstract][Full Text] [Related]
5. Genetics of type 2 diabetes mellitus.
Malecki MT
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S10-21. PubMed ID: 15955369
[TBL] [Abstract][Full Text] [Related]
6. [Non-insulin dependent diabetes in children and adolescents].
Njølstad PR; Søvik O; Bell GI; Cockburn BN; Følling I; Sagen J
Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1054-7. PubMed ID: 9531829
[TBL] [Abstract][Full Text] [Related]
7. Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients.
Hwang JS; Shin CH; Yang SW; Jung SY; Huh N
Diabetes Res Clin Pract; 2006 Oct; 74(1):75-81. PubMed ID: 16632067
[TBL] [Abstract][Full Text] [Related]
8. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
Xu JY; Dan QH; Chan V; Wat NM; Tam S; Tiu SC; Lee KF; Siu SC; Tsang MW; Fung LM; Chan KW; Lam KS
Eur J Hum Genet; 2005 Apr; 13(4):422-7. PubMed ID: 15657605
[TBL] [Abstract][Full Text] [Related]
9. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
[TBL] [Abstract][Full Text] [Related]
10. Molecular and biochemical analysis of the MODY syndromes.
Winter WE
Pediatr Diabetes; 2000 Jun; 1(2):88-117. PubMed ID: 15016234
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Ellard S; Colclough K
Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
[TBL] [Abstract][Full Text] [Related]
12. Maturity onset diabetes of the young--review.
Gat-Yablonski G; Shalitin S; Phillip M
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():514-20. PubMed ID: 17551475
[TBL] [Abstract][Full Text] [Related]
13. Genetic and clinical characteristics of maturity-onset diabetes of the young.
Giuffrida FM; Reis AF
Diabetes Obes Metab; 2005 Jul; 7(4):318-26. PubMed ID: 15955117
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of mutual functional interactions between HNF-4alpha and HNF-1alpha revealed by mutations that cause maturity onset diabetes of the young.
Rowley CW; Staloch LJ; Divine JK; McCaul SP; Simon TC
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G466-75. PubMed ID: 16223942
[TBL] [Abstract][Full Text] [Related]
15. [Molecular diagnosis on indication of maturity onset diabetes of the young; results from 184 patients].
Losekoot M; Broekman AJ; Breuning MH; de Koning EJ; Romijn JA; Maassen JA
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):139-43. PubMed ID: 15693590
[TBL] [Abstract][Full Text] [Related]
16. HNF-4alpha: from MODY to late-onset type 2 diabetes.
Gupta RK; Kaestner KH
Trends Mol Med; 2004 Nov; 10(11):521-4. PubMed ID: 15519277
[TBL] [Abstract][Full Text] [Related]
17. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
Cao H; Shorey S; Robinson J; Metzger DL; Stewart L; Cummings E; Hegele RA
Hum Mutat; 2002 Dec; 20(6):478-9. PubMed ID: 12442280
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies.
Aguilera E; Casamitjana R; Ercilla G; Oriola J; Nicoletti F; Gomis R; Conget I
Diabet Med; 2005 Feb; 22(2):137-43. PubMed ID: 15660729
[TBL] [Abstract][Full Text] [Related]
19. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
Karlsson E; Shaat N; Groop L
Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus.
Sagen JV; Baumann ME; Salvesen HB; Molven A; Søvik O; Njølstad PR
Diabet Med; 2005 Aug; 22(8):1012-5. PubMed ID: 16026366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
